Target intelligence / Profile preview

Not a discrete molecular target

Molecular classification
Other
01

Overview

The designation "Not a discrete molecular target" is used in pharmacology to identify therapeutic agents that do not interact with a specific biological macromolecule, such as a receptor or enzyme, to produce a clinical effect. Instead, these agents work through physicochemical mechanisms that alter the local environment of a tissue or involve direct chemical reactions (Gaulton et al., 2012). For example, antacids like calcium carbonate function by directly neutralizing gastric hydrochloric acid, thereby increasing the pH of the stomach contents to relieve heartburn (Salisbury & Terrell, 2023). Osmotic laxatives, such as polyethylene glycol or magnesium salts, create an osmotic gradient that retains water within the intestinal lumen to facilitate bowel movements (Bashir & Sizar, 2023). Other substances, like simethicone, act as surfactants to reduce the surface tension of gas bubbles, while phosphate binders like sevelamer physically sequester ions in the gut. Because these treatments lack a specific protein binding site, they generally do not exhibit stereoselectivity and often require higher dosages than targeted molecular therapies. This category is essential for classifying drugs that provide significant therapeutic utility through non-biological, bulk physical or chemical interactions.

Other names
Non-molecular targetPhysicochemical mechanism of actionNon-specific mechanismNon-protein target
02

Mechanism of action

Drugs associated with this classification exert their effects through physicochemical processes such as the chemical neutralization of acids, the creation of osmotic gradients to move water, or the physical binding of ions in the gastrointestinal tract.

03

Biological functions

Acid-base neutralizationOsmotic regulationSurface tension modificationPhysical absorption
04

Disease associations

Gastroesophageal reflux diseaseConstipationFlatulenceHyperphosphatemia
05

Safety considerations

Electrolyte imbalanceSystemic accumulation of minerals in patients with renal impairmentAcid-rebound effectInterference with the absorption of co-administered medications
06

Interacting drugs

Calcium carbonate

5 more in the full profile.

07

Biomarkers

Gastric pHStool consistencySerum phosphate levelsSerum electrolyte levels

Beyond the preview

Go deeper on Not a discrete molecular target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Not a discrete molecular target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call